SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors react to Berkshire Hathaway's full exit of its position, a move that sparked significant community debate over whether the sell-off represents a strategic misstep by new leadership or a tactical portfolio rebalancing. While some traders are bracing for short-term volatility or selling into the news, many long-term holders remain bullish, viewing the pullback as a buying opportunity supported by strong fundamental growth and healthcare sector demand.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the announcement of an exclusive U.S. supply agreement for the Tokyo-172 strain of BCG, a strategic move designed to mitigate long-standing domestic shortages and bolster the commercial rollout of its bladder cancer immunotherapy. Community discussion is heavily focused on this supply diversification, alongside intense anticipation for the company's scientific presentations at the American Urological Association conference and the potential impact of ongoing leadership changes at the FDA.

Inter & Co., Inc. Is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Banking, Securities, Insurance Brokerage, Marketplace, Asset Management, Service, and Other. The Banking segment offers checking accounts cards, deposits, loans and advances, and other services through mobile application. The Securities segment is involved in the acquisition, sale and custody of securities, the structuring and distribution of securities in the capital market, and the provision of administration services to investment funds. The Insurance Brokerage segment includes insurance products underwritten by insurance companies, such as warranties, life, property and automobile insurance, and pension products, as well as consortium products provided by a third party. The Marketplace segment operates a digital platform, which offers goods and services to its customers. The Asset Management segment is composed of the operations related to the management of fund portfolios and other assets. The Service segment consists of collection and management of personal information, development and licensing of customized computer programs, development and licensing of non-customized computer programs and technical support, maintenance, and other information technology services. The company was founded on January 26, 2021 and is headquartered in Belo Horizonte, Brazil.

Inter & Co Inc - Ordinary Shares - Class A

INTER  CO INC

Inter & Co is capturing investor attention as it expands its AI-powered super app strategy and targets record growth, leading many in the community to view the stock as undervalued despite recent price volatility. While some participants are wary of macroeconomic headwinds, bulls are actively discussing the company's strong client acquisition and long-term potential, with many advocating for buying into current support levels.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The iShares 20+ Year Treasury Bond ETF is trending as investors grapple with a bond market rout fueled by surging energy prices and renewed inflation fears. Community sentiment is deeply polarized, with many traders anticipating further downside due to structural debt concerns and fiscal policy, while some contrarians eye the potential for a defensive shift if regional conflict resolution sparks a broader market rally.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels Inc. is trending as investors monitor its strategic pivot toward heavy rare earth production and uranium supply chain integration, bolstered by recent high-purity dysprosium and terbium breakthroughs at its White Mesa Mill. The community is actively debating the company's long-term valuation in the context of critical mineral sovereignty and AI-driven energy demand, while balancing short-term volatility against upcoming leadership changes.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is trending as investors weigh strong demand for its AI-focused high-speed networking gear against concerns over potential margin pressures from industry-wide supply chain constraints. The community is actively debating the stock's long-term potential as a critical AI infrastructure provider, often comparing its recent volatility to other sector leaders like Cisco while highlighting institutional analyst upgrades.

Energy Vault Holdings, Inc. engages in the provision of energy storage solutions. The company was founded in September 2020 and is headquartered in Westlake Village, CA.

Energy Vault Holdings Inc

Energy Vault Holdings is gaining attention as investors weigh the company's aggressive expansion into the AI data center energy infrastructure sector against broader market volatility. The community remains focused on upcoming earnings and project-based catalysts, debating whether the company's backlog growth and strategic energy storage partnerships will overcome current short-interest headwinds.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Run Inc. is currently trending as investors focus on its strategic status as an NVIDIA Exemplar Cloud partner and its newly secured multi-billion dollar infrastructure deal with Dell. While the community is actively debating the company's valuation following its recent de-SPAC and potential for future volatility, many traders are closely monitoring its limited float for a potential gamma squeeze.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending as market participants debate whether its rapid ascent represents a genuine infrastructure play fueled by AI-driven demand for 800G and 1.6T optical interconnects or an unsustainable momentum-based bubble. While bulls point to hyperscaler order backlogs and capacity expansions as evidence of a structural re-rating, bears highlight the company's historical lack of profitability and recent equity distribution filings as signs of inevitable dilution and overvaluation.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as investors weigh its role as a domestic supplier of critical minerals against frustration over delayed production timelines and recent quarterly performance. Community discussion remains heavily divided between long-term bulls highlighting the company's strategic value to U.S. defense and skeptics focused on execution concerns and volatile price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Do Options Traders Know Something About Adherex Technologies Stock We Don't?

Investors need to pay close attention to FENC stock based on the movements in the options market lately. 

Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates

Adherex Technologies (FENC) delivered earnings and revenue surprises of +157.14% and +8.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates

MaxCyte (MXCT) delivered earnings and revenue surprises of +57.90% and +31.31%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of 0.00% and -7.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Adherex Technologies (FENC) Expected to Announce Quarterly Earnings on Tuesday

Adherex Technologies (NASDAQ:FENC) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-fennec-pharmaceuticals-inc-stock...

Insider Selling: Adherex Technologies (NASDAQ:FENC) Director Sells 10,781 Shares of Stock

Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) Director Rosty Raykov sold 10,781 shares of the business's stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $6.47, for a total value of $69,753.07. Following the sale, the director owned...

Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven research firms that are presently covering the stock...

Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below Fifty Day Moving Average - Here's What Happened

Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average - What's Next...

Adherex Technologies (NASDAQ:FENC) Given "Outperform" Rating at Wedbush

Wedbush reiterated an "outperform" rating and issued a $13.00 target price on shares of Adherex Technologies in a research note on Thursday...

Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below Fifty Day Moving Average   - What's Next?

Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below Fifty Day Moving Average - Here's What Happened...

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

FENC
Fennec Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest FENC News

FENCFennec Pharmaceuticals Inc